BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34320651)

  • 1. Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925.
    Poortmans PM; Struikmans H; De Brouwer P; Weltens C; Fortpied C; Kirkove C; Budach V; Peignaux-Casasnovas K; van der Leij F; Vonk E; Valli M; vanTienhoven G; Weidner N; Noel G; Guckenberger M; Koiter E; vanLimbergen E; Engelen A; Fourquet A; Bartelink H;
    J Natl Cancer Inst; 2021 Oct; 113(10):1360-1368. PubMed ID: 34320651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
    Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
    Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial.
    Kaidar-Person O; Fortpied C; Hol S; Weltens C; Kirkove C; Budach V; Peignaux-Casasnovas K; van der Leij F; Vonk E; Valli M; Weidner N; Guckenberger M; Koiter E; Fourquet A; Bartelink H; Struikmans H; Poortmans P;
    Radiother Oncol; 2022 Jul; 172():99-110. PubMed ID: 35568284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
    Steenbruggen TG; Steggink LC; Seynaeve CM; van der Hoeven JJM; Hooning MJ; Jager A; Konings IR; Kroep JR; Smit WM; Tjan-Heijnen VCG; van der Wall E; Bins AD; Linn SC; Schaapveld M; Jacobse JN; van Leeuwen FE; Schröder CP; van Tinteren H; de Vries EGE; Sonke GS; Gietema JA
    JAMA Oncol; 2020 Apr; 6(4):528-534. PubMed ID: 31999296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
    Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
    N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
    Budach W; Kammers K; Boelke E; Matuschek C
    Radiat Oncol; 2013 Nov; 8():267. PubMed ID: 24225206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
    Galimberti V; Cole BF; Zurrida S; Viale G; Luini A; Veronesi P; Baratella P; Chifu C; Sargenti M; Intra M; Gentilini O; Mastropasqua MG; Mazzarol G; Massarut S; Garbay JR; Zgajnar J; Galatius H; Recalcati A; Littlejohn D; Bamert M; Colleoni M; Price KN; Regan MM; Goldhirsch A; Coates AS; Gelber RD; Veronesi U;
    Lancet Oncol; 2013 Apr; 14(4):297-305. PubMed ID: 23491275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of arm draining lymph node in relation to breast cancer radiotherapy field and target volume.
    Wang W; Ward R; Jia D; Ashworth S; Estoesta E; Moodie T; Ahern V; Stuart K; Ngui N; French J; Elder E; Farlow D
    Radiother Oncol; 2019 Apr; 133():193-197. PubMed ID: 30446320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit?
    Obedian E; Haffty BG
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):997-1003. PubMed ID: 10421532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
    Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
    J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis.
    Sanghani M; Balk EM; Cady B
    Cancer; 2009 Apr; 115(8):1613-20. PubMed ID: 19199349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.